Key Finding
Combined electroacupuncture and methotrexate treatment synergistically reduced psoriatic inflammation more effectively than either therapy alone by rebalancing Th17/Treg immune responses and suppressing NF-κB activation.
Researchers investigated whether electroacupuncture could help treat psoriasis, a chronic inflammatory skin condition, both alone and in combination with methotrexate (MTX), a common medication for psoriasis. Using a mouse model of psoriasis-like skin inflammation, scientists tested electroacupuncture treatment, MTX alone, and both therapies together.
The study found that electroacupuncture by itself reduced skin lesions, improved skin appearance, and decreased inflammatory chemicals in the skin. MTX also showed similar benefits. However, when electroacupuncture and MTX were used together, the results were even better than either treatment alone, with greater reduction in skin inflammation and improved healing.
The research revealed how these treatments work at the cellular level. Both electroacupuncture and MTX helped balance the immune system by reducing inflammatory Th17 cells while increasing regulatory T cells (Tregs) that help control inflammation. The combination therapy enhanced this balancing effect. The treatments also suppressed a key inflammatory pathway called NF-κB, which plays a central role in psoriasis inflammation.
What this means for patients: This study suggests that electroacupuncture may be a valuable complementary therapy for psoriasis, potentially allowing patients to achieve better results when combined with standard medications. The combination approach might also mean lower doses of medication are needed, potentially reducing side effects. While this research was conducted in mice and human studies are still needed, it provides scientific evidence for acupuncture's anti-inflammatory effects in psoriasis. If you're considering acupuncture for psoriasis, consult with a board-certified, licensed acupuncturist experienced in treating dermatological conditions.
This study examined electroacupuncture (EA) as monotherapy and adjunctive treatment with methotrexate (MTX) in imiquimod-induced psoriatic mice. Results demonstrated that EA alone significantly ameliorated psoriasiform lesions, improved histopathology, and reduced proinflammatory cytokines. Combined EA+MTX therapy showed superior efficacy compared to either modality alone.
Mechanistically, EA and MTX decreased CD4+ IL-17A+ Th17 cell percentages in skin and lymph nodes while downregulating RORγt expression. Conversely, CD4+ FoxP3+ Treg frequencies increased with both treatments, with maximal effect observed in combination therapy. Treg depletion experiments reversed therapeutic benefits, confirming their mechanistic importance. Both interventions suppressed phosphorylated NF-κB (p65) expression, and NF-κB agonist administration negated anti-inflammatory effects.
Clinical implications: EA demonstrates immunomodulatory effects through Th17/Treg rebalancing and NF-κB pathway suppression. Combined EA-MTX therapy may enable dose reduction of immunosuppressants while maintaining or enhancing therapeutic efficacy, potentially minimizing adverse effects. These findings support EA as evidence-based adjunctive therapy for psoriasis management, warranting clinical trials in human populations.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 TENS therapy at 10 Hz with sacral electrode placement significantly reduced urinary and fecal incontinence in pediatric patients with non-neurological pelvic floor dysfunctions, particularly when combined with biofeedback or behavioral therapy.
📌 All three dry eye disease patients showed significant improvements in ocular fatigue and dryness after only 3-4 days of electroacupuncture treatment, with sustained results at 4-week follow-up.
📌 Electroacupuncture at ST36 reduced demyelination and inflammation in EAE mice while increasing populations of neural, hematopoietic, and mesenchymal stem cells, suggesting stem cell regulation as a potential therapeutic mechanism.